NO20054523L - Hydroksymetyl-substituerte dihydroisoksazolderivater som er nyttige som antibiotika - Google Patents

Hydroksymetyl-substituerte dihydroisoksazolderivater som er nyttige som antibiotika

Info

Publication number
NO20054523L
NO20054523L NO20054523A NO20054523A NO20054523L NO 20054523 L NO20054523 L NO 20054523L NO 20054523 A NO20054523 A NO 20054523A NO 20054523 A NO20054523 A NO 20054523A NO 20054523 L NO20054523 L NO 20054523L
Authority
NO
Norway
Prior art keywords
sub
hydroxymethyl
antibiotics
hydrogen
derivatives useful
Prior art date
Application number
NO20054523A
Other languages
English (en)
Other versions
NO20054523D0 (no
Inventor
Michael Barry Gravestock
Neil James Hales
Daniel Robert Carcanague
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0304723A external-priority patent/GB0304723D0/en
Priority claimed from GB0318607A external-priority patent/GB0318607D0/en
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20054523D0 publication Critical patent/NO20054523D0/no
Publication of NO20054523L publication Critical patent/NO20054523L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Forbindelser av formel (I), eller et farmasøytisk akseptabelt salt, eller en in-vivo hydrolserbar ester derav, hvoi Ria er -NH(C=W)R5 eller
NO20054523A 2003-03-01 2005-09-30 Hydroksymetyl-substituerte dihydroisoksazolderivater som er nyttige som antibiotika NO20054523L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0304723A GB0304723D0 (en) 2003-03-01 2003-03-01 Chemical compounds
GB0318607A GB0318607D0 (en) 2003-08-08 2003-08-08 Chemical compounds
PCT/GB2004/000730 WO2004078753A1 (en) 2003-03-01 2004-02-24 Hydroxymethyl substituted dihydroisoxazole derivatives useful as antibiotic agents

Publications (2)

Publication Number Publication Date
NO20054523D0 NO20054523D0 (no) 2005-09-30
NO20054523L true NO20054523L (no) 2005-12-01

Family

ID=32964061

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054523A NO20054523L (no) 2003-03-01 2005-09-30 Hydroksymetyl-substituerte dihydroisoksazolderivater som er nyttige som antibiotika

Country Status (17)

Country Link
US (1) US7192974B2 (no)
EP (1) EP1599471B1 (no)
JP (1) JP2006519247A (no)
KR (1) KR20050106064A (no)
AT (1) ATE396991T1 (no)
AU (1) AU2004218206A1 (no)
BR (1) BRPI0407835A (no)
CA (1) CA2517706A1 (no)
CL (1) CL2004000400A1 (no)
DE (1) DE602004014107D1 (no)
ES (1) ES2305732T3 (no)
HK (1) HK1083097A1 (no)
MX (1) MXPA05009205A (no)
NO (1) NO20054523L (no)
TW (1) TW200500360A (no)
UY (1) UY28211A1 (no)
WO (1) WO2004078753A1 (no)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE304536T1 (de) * 2001-04-17 2005-09-15 Merck & Co Inc Bicyclo(3,1,0)hexan als strukturelement enthaltende oxazolidinon-antibiotika und deren derivate
CN1653064A (zh) 2002-02-28 2005-08-10 阿斯特拉曾尼卡有限公司 噁唑烷酮衍生物、其制备方法以及包含它们的药用组合物
CA2477344A1 (en) 2002-02-28 2003-09-04 Astrazeneca Ab 3-cyclyl-5-(nitrogen-containing 5-membered ring) methyl-oxazolidinone derivatives and their use as antibacterial agents
WO2005012271A2 (en) * 2003-07-29 2005-02-10 Rib-X Pharmaceuticals, Inc. Process for the synthesis of biaryl oxazolidinones
US8324398B2 (en) 2003-06-03 2012-12-04 Rib-X Pharmaceuticals, Inc. Process for the synthesis of biaryl oxazolidinones
TWI378092B (en) 2003-06-03 2012-12-01 Rib X Pharmaceuticals Inc Biaryl heterocyclic compounds and methods of making and using the same
BRPI0411688A (pt) * 2003-07-02 2006-12-26 Merck & Co Inc antibióticos de oxazolidinona substituìda de grupo de ciclopropil e seus derivados
WO2005005422A1 (en) * 2003-07-02 2005-01-20 Merck & Co., Inc. Oxazolidinone antibiotics and derivatives thereof
AU2004256084B2 (en) * 2003-07-02 2007-10-18 Kyorin Pharmaceutical Co., Ltd. Oxazolidinone antibiotics and derivatives thereof
JP2007521283A (ja) * 2003-07-02 2007-08-02 メルク アンド カンパニー インコーポレーテッド シクロプロピル基で置換されたオキサゾリジノン系抗生物質およびその誘導体
ES2536001T3 (es) * 2003-07-29 2015-05-19 Melinta Therapeutics, Inc. Procedimiento para la síntesis de biariloxazolidinonas
WO2005033079A1 (ja) 2003-09-30 2005-04-14 Eisai Co., Ltd. ヘテロ環化合物を含有する新規な抗真菌剤
WO2005061468A1 (en) 2003-12-17 2005-07-07 Rib-X Pharmaceuticals, Inc. Halogenated biaryl heterocyclic compounds and methods of making and using the same
KR100854211B1 (ko) * 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
US20050241110A1 (en) * 2004-04-09 2005-11-03 Bruce Baker Ergonomic handles, especially for garden tools
GB0411596D0 (en) * 2004-05-25 2004-06-30 Astrazeneca Ab Chemical process
US20080064689A1 (en) * 2004-05-25 2008-03-13 Astrazeneca Ab 3-[4-(6-Pyridin-3-Yl)-3-Phenyl] -5-(1H-1,2,3-Triazol-1-Ylmethyl)-1,3-Oxazolidin-2-Ones as Antibacterial Agents
WO2005116024A1 (en) * 2004-05-25 2005-12-08 Astrazeneca Ab 3- (4- (2-dihydroisoxazol-3-ylpyridin-5-yl) phenyl) -5-triazol-1-ylmethyloxazolidin-2-one derivaives as mao inhibitors for the treatment of bacterial infections
US20100286211A1 (en) * 2004-10-08 2010-11-11 Biswajit Das Oxazolidinone derivatives as antimicrobials
US20100047338A1 (en) 2008-03-14 2010-02-25 Angela Brodie Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens, In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity
WO2006106711A1 (ja) 2005-03-30 2006-10-12 Eisai R & D Management Co., Ltd. ピリジン誘導体を含有する抗真菌剤
ATE496914T1 (de) 2005-06-08 2011-02-15 Rib X Pharmaceuticals Inc Verfahren zur synthese von triazolen
TWI385169B (zh) * 2005-10-31 2013-02-11 Eisai R&D Man Co Ltd 經雜環取代之吡啶衍生物及含有彼之抗真菌劑
WO2007052479A1 (ja) * 2005-11-04 2007-05-10 Ngk Insulators, Ltd. ハニカム構造体及びハニカム触媒体
US8119667B2 (en) * 2005-12-29 2012-02-21 Schering-Plough Animal Health Corporation Carbonates of fenicol antibiotics
WO2008035726A1 (fr) * 2006-09-21 2008-03-27 Eisai R & D Management Co., Ltd. Dérivé de pyridine substitué par un cycle hétéroaryle, et agent antifongique le comprenant
US8258394B2 (en) * 2007-02-08 2012-09-04 Bradford G Baruh Retractable solar panel system
US20080190341A1 (en) * 2007-02-08 2008-08-14 Baruh Bradford G System and method of adjusting the location and position of the foresail on a sailboat
US20100065104A1 (en) * 2007-08-31 2010-03-18 Baruh Bradford G Retractable solar panel system
KR100848232B1 (ko) * 2007-04-12 2008-07-24 일동제약주식회사 신규 헤테로 고리 또는 알콕시아미노메틸 옥사졸리디논 및그 제조방법
TW200841879A (en) * 2007-04-27 2008-11-01 Eisai R&D Man Co Ltd Pyridine derivatives substituted by heterocyclic ring and phosphonoamino group, and anti-fungal agent containing same
JPWO2008136279A1 (ja) 2007-04-27 2010-07-29 エーザイ・アール・アンド・ディー・マネジメント株式会社 ヘテロ環置換ピリジン誘導体の塩またはその結晶
EP2166838B1 (en) * 2007-06-01 2018-10-24 CHX Technologies Inc. Topical dental solution of chlorhexidine in sumatra benzoin bp/ep and methods of manufacturing and evaluating same
US8513287B2 (en) 2007-12-27 2013-08-20 Eisai R&D Management Co., Ltd. Heterocyclic ring and phosphonoxymethyl group substituted pyridine derivatives and antifungal agent containing same
GB2470700B (en) 2008-03-25 2012-08-08 Univ Maryland C-17 heteroaryl steroidal CYP17 inhibitors
CA2712613C (en) 2008-03-26 2017-02-28 Global Alliance For Tb Drug Development Bicyclic nitroimidazoles covalently linked to substituted phenyl oxazolidinones
MX366793B (es) * 2008-10-10 2019-07-24 Merck Sharp & Dohme Corp Star Metodos para preparar oxazolidinonas y composiciones que las contienen.
US8188119B2 (en) 2008-10-24 2012-05-29 Eisai R&D Management Co., Ltd Pyridine derivatives substituted with heterocyclic ring and γ-glutamylamino group, and antifungal agents containing same
SG173497A1 (en) 2009-02-03 2011-09-29 Trius Therapeutics Crystalline form of r)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate
AU2010210422A1 (en) 2009-02-05 2011-08-18 Tokai Pharmaceuticals, Inc. Novel prodrugs of steroidal CYP17 inhibitors/antiandrogens
KR20110136850A (ko) * 2009-03-13 2011-12-21 썬 케미칼 비.브이. 에너지-경화성 조성물에 유용한 사이클릭 카바메이트 화합물
US8580767B2 (en) * 2009-05-28 2013-11-12 Trius Therapeutics, Inc. Oxazolidinone containing dimer compounds, compositions and methods to make and use
KR101653570B1 (ko) * 2011-03-30 2016-09-02 주식회사 레고켐 바이오사이언스 신규한 옥사졸리디논 유도체 및 이를 함유하는 의약 조성물
EP2626356A1 (en) * 2012-02-08 2013-08-14 Rheinische Friedrich-Wilhelms-Universität Bonn Thiamine analogues and their use as antibiotics
CA2904170A1 (en) 2013-03-14 2014-09-25 University Of Maryland, Baltimore Androgen receptor down-regulating agents and uses thereof
WO2015023710A1 (en) 2013-08-12 2015-02-19 Tokai Pharmaceuticals, Inc. Biomarkers for treatment of neoplastic disorders using androgen-targeted therapies
CN112707779B (zh) * 2020-12-26 2023-06-30 蚌埠中实化学技术有限公司 一种乙烯基环己烷的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4948801A (en) * 1988-07-29 1990-08-14 E. I. Du Pont De Nemours And Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
DE69216251T2 (de) * 1991-11-01 1997-05-15 Pharmacia & Upjohn Co., Kalamazoo, Mich. Substituierte aryl- und heteroaryl-phenyloxazolidinone
MXPA02012045A (es) * 2000-06-05 2003-10-15 Dong A Pharm Co Ltd Nuevos derivados de oxazolidinona y proceso para su preparacion.
US20020115669A1 (en) 2000-08-31 2002-08-22 Wiedeman Paul E. Oxazolidinone chemotherapeutic agents
PL369183A1 (en) * 2001-09-11 2005-04-18 Astrazeneca Ab Oxazolidinone and/or isoxazoline as antibacterial agents
GB0227701D0 (en) * 2002-11-28 2003-01-08 Astrazeneca Ab Chemical compounds
AU2003302404B2 (en) * 2002-11-28 2008-06-19 Astrazeneca Ab Oxazolidinone and / or isoxazoline derivatives as antibacterial agents
GB0229526D0 (en) * 2002-12-19 2003-01-22 Astrazeneca Ab Chemical compounds

Also Published As

Publication number Publication date
US20060270637A1 (en) 2006-11-30
CL2004000400A1 (es) 2005-04-22
BRPI0407835A (pt) 2006-02-14
AU2004218206A1 (en) 2004-09-16
NO20054523D0 (no) 2005-09-30
KR20050106064A (ko) 2005-11-08
CA2517706A1 (en) 2004-09-16
ES2305732T3 (es) 2008-11-01
MXPA05009205A (es) 2005-10-18
WO2004078753A1 (en) 2004-09-16
TW200500360A (en) 2005-01-01
EP1599471B1 (en) 2008-05-28
HK1083097A1 (en) 2006-06-23
ATE396991T1 (de) 2008-06-15
DE602004014107D1 (de) 2008-07-10
EP1599471A1 (en) 2005-11-30
JP2006519247A (ja) 2006-08-24
US7192974B2 (en) 2007-03-20
UY28211A1 (es) 2004-09-30

Similar Documents

Publication Publication Date Title
NO20054523D0 (no) Hydroksymetyl-substituerte dihydroisoksazolderivater som er nyttige som antibiotika
NO20024614D0 (no) N-heterosykliske derivater som NOS-hemmere
WO2001077107A8 (en) Oxazole derivatives and their uses as tyrosine kinase inhibitors
WO2007016392A3 (en) Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors
NO20083207L (no) Inhibitorer av IAP
MXPA05009969A (es) Metodo para aislar la forma cristalina i de la 5-azacitidina.
MY132698A (en) Herbicidal composition
GB0129476D0 (en) Organic compounds
WO2003082205A3 (en) Compounds and methods
NO20052074L (no) Substituerte benzoksazinoner og anvendelser derav.
EP1591120A4 (en) RECEPTOR AGONISTS
AU2003222106A1 (en) Thiopene-based tricyclic compounds and pharmaceutical compositions comprising same
WO2005003087A3 (en) Oxazole derivatives as antibacterial agents
NO20061317L (no) Imidazopyridinderivater som induserbare NO-syntaseinhibatorer
ATE398627T1 (de) C-2-modifizierte erythromycinderivate
RS97004A (en) Benzoxazine derivatives as 5-ht6 modulators and uses thereof
NO20035791L (no) Nye derivater av oksazolidinoner som antibakterielle midler
WO2003072576A3 (en) Oxazolidinone derivatives, processes for their preparation, and pharmaceutical compositions containing them
WO2022106469A3 (en) N-(2,3-dihydro-1,4-benzoxazin-4-yl)-3-isopropyl-7-(2,3,5-trifluorophenyl)benzo-thiophene-2-carboxamide derivatives and similar compounds for the treatment of heartworm infections
ATE453389T1 (de) Bestimmte pharmazeutisch wertvolle substituierte aminoalkyl-heterocyclen
WO2007014839A3 (en) Cathepsin k inhibitors
GEP20074256B (en) Novel benzothiadiazine, process for their preparation and pharmaceutical compositions containing
NO20061344L (no) Imidazopyridinderivater som induserbare NO-syntaseoinhibitorer
HUP0402341A2 (hu) Szubsztituált tiazol-2-ilaminokat tartalmazó készítmények rák kezelésére
DK1899331T3 (da) Homomorpholinoxazolidnoner som antibakterielle midler

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application